Safeguard Scientifics, Inc. (SFE)
(Delayed Data from NYSE)
$11.72 USD
+0.42 (3.72%)
Updated May 3, 2019 04:02 PM ET
After-Market: $11.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.72 USD
+0.42 (3.72%)
Updated May 3, 2019 04:02 PM ET
After-Market: $11.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Safeguard Scientifics Enters Oversold Territory
by Zacks Equity Research
Safeguard Scientifics, Inc. (SFE) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
The Zacks Analyst Blog Highlights: Oasis Midstream, Safeguard Scientifics, Fly Leasing, Limbach and StealthGas
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Oasis Midstream, Safeguard Scientifics, Fly Leasing, Limbach and StealthGas
5 Momentum Stocks to Buy on a Likely Fed Rate Cut
by Manaswita Ghosh Dutta
Investing in momentum stocks could be a great way to profit off a round of Fed rate cuts, per Goldman.
Earnings Estimates Moving Higher for Safeguard Scientifics (SFE): Time to Buy?
by Zacks Equity Research
Safeguard Scientifics (SFE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks.com highlights: Safeguard Scientifics, Exantas Capital, Champions Oncology, Stars Group and GDS Holdings
by Zacks Equity Research
Zacks.com highlights: Safeguard Scientifics, Exantas Capital, Champions Oncology, Stars Group and GDS Holdings
5 Stocks to Buy as New Analysts Show Interest
by Zacks Equity Research
Increased analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.
Safeguard Scientifics Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Safeguard Scientifics has been struggling lately, but the selling pressure may be coming to an end soon.
Saratoga Investment (SAR) in Focus: Stock Moves 5.9% Higher
by Zacks Equity Research
Saratoga Investment (SAR) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
Safeguard Scientifics (SFE) Catches Eye: Stock Jumps 11.7%
by Zacks Equity Research
Safeguard Scientifics, Inc. (SFE) was a big mover last session, as the company saw its shares rise nearly 12% on the day.